Publications

Export 33 results:
Author Title [ Type(Desc)] Year
Filters: Author is Bruno Giros  [Clear All Filters]
Journal Article
Sakae DY, Marti F, Lecca S, Vorspan F, Martín-García E, Morel LJ, Henrion A, Gutiérrez-Cuesta J, Besnard A, Heck N et al..  2015.  The absence of VGLUT3 predisposes to cocaine abuse by increasing dopamine and glutamate signaling in the nucleus accumbens.. Mol Psychiatry. 20(11):1448-59.
Orrico-Sanchez A, Chausset-Boissarie L, de Sousa RAlves, Coutens B, Amin SRezai, Vialou V, Louis F, Hessani A, Dansette PM, Zornoza T et al..  2019.  Antidepressant efficacy of a selective organic cation transporter blocker in a mouse model of depression.. Mol Psychiatry.
Apazoglou K, Farley S, Gorgievski V, Belzeaux R, Lopez JPablo, Grenier J, Ibrahim EChérif, Khoury M-AEl, Tse YC, Mongredien R et al..  2018.  Antidepressive effects of targeting ELK-1 signal transduction.. Nat Med. 24(5):591-597.
Giros B.  2018.  [Biological psychiatry v3.0].. Med Sci (Paris). 34(11):899-900.
Couroussé T, Bacq A, Belzung C, Guiard B, Balasse L, Louis F, Le Guisquet A-M, Gardier AM, Schinkel AH, Giros B et al..  2015.  Brain organic cation transporter 2 controls response and vulnerability to stress and GSK3β signaling.. Mol Psychiatry. 20(7):889-900.
Santos MDos, Cahill EN, Dal Bo G, Vanhoutte P, Caboche J, Giros B, Heck N.  2017.  Cocaine increases dopaminergic connectivity in the nucleus accumbens.. Brain Struct Funct.
De Gois S, Slama P, Pietrancosta N, Erdozain AM, Louis F, Bouvrais-Veret C, Daviet L, Giros B.  2015.  Ctr9, a Protein in the Transcription Complex Paf1, Regulates Dopamine Transporter Activity at the Plasma Membrane.. J Biol Chem. 290(29):17848-62.
Manitt C, Eng C, Pokinko M, Ryan RT, Torres-Berrío A, Lopez JP, Yogendran SV, Daubaras MJJ, Grant A, Schmidt ERE et al..  2013.  dcc orchestrates the development of the prefrontal cortex during adolescence and is altered in psychiatric patients.. Transl Psychiatry. 3:e338.
C Filho DDe Magalha, Kappeler L, Dupont J, Solinc J, Villapol S, Denis C, Nosten-Bertrand M, Billard J-M, Blaise A, Tronche F et al..  2017.  Deleting IGF-1 receptor from forebrain neurons confers neuroprotection during stroke and upregulates endocrine somatotropin.. J Cereb Blood Flow Metab. 37(2):396-412.
Petrelli F, Dallérac G, Pucci L, Calì C, Zehnder T, Sultan S, Lecca S, Chicca A, Ivanov A, Asensio CS et al..  2018.  Dysfunction of homeostatic control of dopamine by astrocytes in the developing prefrontal cortex leads to cognitive impairments.. Mol Psychiatry.
Cavarec F, Krauss P, Witkowski T, Broisat A, Ghezzi C, De Gois S, Giros B, Depaulis A, Deransart C.  2019.  Early reduced dopaminergic tone mediated by D3 receptor and dopamine transporter in absence epileptogenesis.. Epilepsia. 60(10):2128-2140.
Doly S, Shirvani H, Gäta G, Meye FJ, Emerit M-B, Enslen H, Achour L, Pardo-Lopez L, Yang S-K, Armand V et al..  2015.  GABAB receptor cell-surface export is controlled by an endoplasmic reticulum gatekeeper.. Mol Psychiatry.
Pilorge M, Fassier C, Le Corronc H, Potey A, Bai J, De Gois S, Delaby E, Assouline B, Guinchat V, Devillard F et al..  2015.  Genetic and functional analyses demonstrate a role for abnormal glycinergic signaling in autism.. Mol Psychiatry.
Isingrini E, Guinaudie C, Perret LC, Rainer Q, Moquin L, Gratton A, Giros B.  2017.  Genetic elimination of dopamine vesicular stocks in the nigrostriatal pathway replicates Parkinson's disease motor symptoms without neuronal degeneration in adult mice.. Sci Rep. 7(1):12432.
Belzeaux R, Gorgievski V, Fiori LM, Lopez JPablo, Grenier J, Lin R, Nagy C, Ibrahim EChérif, Gascon E, Courtet P et al..  2020.  GPR56/ADGRG1 is associated with response to antidepressant treatment.. Nat Commun. 11(1):1635.
Nair AG, Castro LRV, Khoury MEl, Gorgievski V, Giros B, Tzavara ET, Hellgren-Kotaleski J, Vincent P.  2019.  The high efficacy of muscarinic M4 receptor in D1 medium spiny neurons reverses striatal hyperdopaminergia.. Neuropharmacology. 146:74-83.
Crépeaux G, Eidi H, David M-O, Tzavara E, Giros B, Exley C, Curmi PA, Shaw CA, Gherardi RK, Cadusseau J.  2015.  Highly delayed systemic translocation of aluminum-based adjuvant in CD1 mice following intramuscular injections.. J Inorg Biochem. 152:199-205.
Blum ID, Zhu L, Moquin L, Kokoeva MV, Gratton A, Giros B, Storch K-F.  2014.  A highly tunable dopaminergic oscillator generates ultradian rhythms of behavioral arousal.. Elife. 3
Giguère N, Delignat-Lavaud B, Herborg F, Voisin A, Li Y, Jacquemet V, Anand-Srivastava M, Gether U, Giros B, Trudeau L-É.  2019.  Increased vulnerability of nigral dopamine neurons after expansion of their axonal arborization size through D2 dopamine receptor conditional knockout.. PLoS Genet. 15(8):e1008352.
Bai J, Blot K, Tzavara E, Nosten-Bertrand M, Giros B, Otani S.  2014.  Inhibition of dopamine transporter activity impairs synaptic depression in rat prefrontal cortex through over-stimulation of D1 receptors.. Cereb Cortex. 24(4):945-55.
Poirel O, Mamer LE, Herman MA, Arnulf-Kempcke M, Kervern M, Potier B, Miot S, Wang J, Favre-Besse F-C, Brabet I et al..  2019.  LSP5-2157 a new inhibitor of vesicular glutamate transporters.. Neuropharmacology. 164:107902.
Bhardwaj SK, Cui Q, Moquin L, Gratton A, Giros B, Srivastava LK.  2021.  Mice with dopaminergic neuron-specific deletion of DTNBP-1 gene show blunted nucleus accumbens dopamine release and associated behaviors.. Neuropharmacology. 184:108440.
Torres-Platas SG, Comeau S, Rachalski A, Dal Bo G, Cruceanu C, Turecki G, Giros B, Mechawar N.  2014.  Morphometric characterization of microglial phenotypes in human cerebral cortex.. J Neuroinflammation. 11:12.
Bimpisidis Z, König N, Stagkourakis S, Zell V, Vlcek B, Dumas S, Giros B, Broberger C, Hnasko TS, Wallén-Mackenzie Å.  2019.  The NeuroD6 Subtype of VTA Neurons Contributes to Psychostimulant Sensitization and Behavioral Reinforcement.. eNeuro. 6(3)
Rocchetti J, Isingrini E, Dal Bo G, Sagheby S, Menegaux A, Tronche F, Levesque D, Moquin L, Gratton A, Wong TPan et al..  2015.  Presynaptic D2 dopamine receptors control long-term depression expression and memory processes in the temporal hippocampus.. Biol Psychiatry. 77(6):513-25.

Pages